Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III randomized observer-blind active-controlled study of recombinant DTaP vaccine versus licensed non-recombinant DTaP in healthy toddlers
TCTR20200325002Phase 3Completed
- Sponsor
- Vaccine Trial Centre
- Start
- Jul 2020
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria, tetanus, and acellular pertussis vaccine in diphtheria, Tetanus, pertussis, sponsored by Vaccine Trial Centre. Started Jul 2020; status: completed.
02
Drugs
diphtheria, tetanus, and acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on TCTR20200325002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200325002.